1-2 of 2
Sora Baek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-l-glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer

Sora Baek, Chang-Min Choi, Sei Hyun Ahn, Jong Won Lee, Gyungyub Gong, Jin-Sook Ryu, Seung Jun Oh, Claudia Bacher-Stier, Lüder Fels, Norman Koglin, Christina Hultsch, Christoph A. Schatz, Ludger M. Dinkelborg, Erik S. Mittra, Sanjiv S. Gambhir, Dae Hyuk Moon
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5427–5437.
https://doi.org/10.1158/1078-0432.CCR-12-0214
Published: 30 September 2012
View article titled, Exploratory Clinical Trial of (4<em>S</em>)-4-(3-[<sup>18</sup>F]fluoropropyl)-<sc>l</sc>-glutamate for Imaging x<sub>C</sub><sup>−</sup> Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer
Open the PDF for Exploratory Clinical Trial of (4<em>S</em>)-4-(3-[<sup>18</sup>F]fluoropropyl)-<sc>l</sc>-glutamate for Imaging x<sub>C</sub><sup>−</sup> Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer in another window
Includes: Multimedia, Supplementary data
Journal Articles

FDG-PET as a Potential Tool for Selecting Patients with Advanced Non–Small Cell Lung Cancer Who May Be Spared Maintenance Therapy after First-Line Chemotherapy

Dok Hyun Yoon, Sora Baek, Chang-Min Choi, Dae Ho Lee, Cheolwon Suh, Jin-Sook Ryu, Dae Hyuk Moon, Jung Shin Lee, Sang-We Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (15): 5093–5100.
https://doi.org/10.1158/1078-0432.CCR-10-2791
Published: 31 July 2011
View article titled, FDG-PET as a Potential Tool for Selecting Patients with Advanced Non–Small Cell Lung Cancer Who May Be Spared Maintenance Therapy after First-Line Chemotherapy
Open the PDF for FDG-PET as a Potential Tool for Selecting Patients with Advanced Non–Small Cell Lung Cancer Who May Be Spared Maintenance Therapy after First-Line Chemotherapy in another window
Includes: Supplementary data